BARCLAYS PLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 312069 LONDON, X0

Position in PYXS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,052

-$58,691 QoQ

Shares Held

4,669

-90.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#62

of 76 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. PYXS ranks #318 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,052	4,669	-90.6%	Shares	Defined	2026-08-14
2026-03-31	$72,743	49,825	-17.5%	Shares	Defined	2026-05-15
2025-12-31	$69,441	60,385	+1939.3%	Shares	Sole	2026-02-13
2025-09-30	$6,573	2,961	-39.0%	Shares	Sole	2026-03-31
2025-06-30	$5,339	4,854	-91.0%	Shares	Sole	2026-02-27
2025-03-31	$53,026	54,109	-29.7%	Shares	Sole	2026-03-17
2024-12-31	$120,140	77,013	+20.2%	Shares	Sole	2026-03-19
2024-09-30	$235,206	64,089	+275.0%	Shares	Sole	2026-03-31
2024-06-30	$56,574	17,092	-85.5%	Shares	Sole	2026-03-23
2023-03-31	$474,074	118,223	-87.5%	Shares	Sole	2026-03-30
2022-12-31	$1,270,388	948,051	+0.0%	Shares	Sole	2026-03-30
2022-09-30	$1,866,872	947,651	0.0%	Shares	Sole	2022-11-03
2022-06-30	$2,255,409	947,651	-0.2%	Shares	Sole	2022-08-12
2022-03-31	$3,835,523	949,387	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.